All Posts: clinical trials

• New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients

  A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.

  Category: News Release Tags: cancer, cancer research, clinical trials, immunotherapy, melanoma, mRNA vaccine, research

• Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials

  Held by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center, the Ruesch Symposium brings together researchers, clinicians, patients, caregivers, policymakers and advocates for networking and discussion on the latest developments in GI cancer research and treatment.

  Category: GUMC Stories Tags: clinical trials, gastrointestinal cancer, Georgetown Lombardi, pancreatic cancer, patient care, research, Ruesch Center, Ruesch Center Symposium

• The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology

  Category: News Release Tags: cancer, clinical trials, immunotherapy, research

• Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy

  Category: News Release Tags: cancer, clinical trials, Georgetown Lombardi, immunotherapy, melanoma, research

• Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer

  Category: GUMC Stories Tags: breast cancer, cancer, cancer research, clinical trials, Georgetown Lombardi

• FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research

  Category: GUMC Stories Tags: cancer, clinical trials, Georgetown Lombardi, lung cancer

• Clinical Research Staff Rise to the Challenges Posed by Pandemic

  (July 31, 2020) — Running clinical research can be complicated under normal circumstances but it’s especially arduous during a pandemic. Despite the difficulties, the clinical research teams at Georgetown have worked tirelessly, remotely and on campus, to continue supporting researchers and study participants. “Our team as a whole really stepped up to do this, and […]

  Category: GUMC Stories Tags: clinical research coordinators, clinical trials, COVID-19, Huntington's disease

• First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight

  Category: GUMC Stories Tags: breast cancer, cancer, clinical trials, Georgetown Lombardi, mammography

• Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial

  WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]

  Category: News Release Tags: Alzheimer's disease, biomedical research, brain, brain research, clinical trials, dementia, mind, nilotinib

• Pressure to Endorse Use of Unproven Drugs for COVID-19 Threatens Public Confidence

  WASHINGTON (April 16, 2020) — The widespread use of experimental treatments for COVID-19, including the antimalarial drugs chloroquine and hydroxychloroquine, represents “ill-advised and uncontrolled human experimentation with unproven treatments,” say two former FDA chief scientists. Furthermore, political pressure or advocacy for specific experimental treatments, such as that surrounding the issuance of an Emergency Use Authorization […]

  Category: News Release Tags: chloroquine, clinical trials, COVID-19, experimental treatments, hydroxychloroquine